Form 8-K - Current report:
SEC Accession No. 0001193125-23-190185
Filing Date
2023-07-20
Accepted
2023-07-20 08:31:31
Documents
14
Period of Report
2023-07-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d530487d8k.htm   iXBRL 8-K 33823
2 EX-10.1 d530487dex101.htm EX-10.1 95916
6 GRAPHIC g530487g65z30.jpg GRAPHIC 11544
  Complete submission text file 0001193125-23-190185.txt   297897

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA amrn-20230718.xsd EX-101.SCH 2522
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE amrn-20230718_lab.xml EX-101.LAB 19337
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amrn-20230718_pre.xml EX-101.PRE 12085
8 EXTRACTED XBRL INSTANCE DOCUMENT d530487d8k_htm.xml XML 3887
Mailing Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60
Business Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60 353 1 6699 020
AMARIN CORP PLC\UK (Filer) CIK: 0000897448 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21392 | Film No.: 231098157
SIC: 2834 Pharmaceutical Preparations